{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:41:52Z","timestamp":1789760512944,"version":"4.0.1"},"reference-count":162,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G065421N"],"award-info":[{"award-number":["G065421N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G0A5624N"],"award-info":[{"award-number":["G0A5624N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001862","name":"Swedish Research Council Formas","doi-asserted-by":"publisher","award":["2020-02293"],"award-info":[{"award-number":["2020-02293"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007067","name":"Kempe Foundations","doi-asserted-by":"publisher","award":["SMK-1954"],"award-info":[{"award-number":["SMK-1954"]}],"id":[{"id":"10.13039\/501100007067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007067","name":"Kempe Foundations","doi-asserted-by":"publisher","award":["SMK21-0069"],"award-info":[{"award-number":["SMK21-0069"]}],"id":[{"id":"10.13039\/501100007067","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Given the medical importance and challenges related to kinetoplastid diseases, a strategic roadmap is needed for the identification of high-quality leads and drug development candidates. Within the aim to deliver more compelling proof-of-concept read-outs, this part proposes a systematic flow-chart of laboratory experiments and decision criteria, focusing on African trypanosomiasis, Chagas disease and visceral and cutaneous leishmaniasis. Next to precision experimental design and reporting, an overview is provided of various complementary laboratory models reproducing kinetoplastid infection and disease. Technical aspects of conventional in vitro and in vivo approaches and, more recently, in silico methods are presented with reference to specific preclinical R&amp;D stages from \u2018hit finding\u2019 to \u2018profiling of a confirmed hit\u2019, covering the expertise areas of medicinal chemistry, primary pharmacology, (eco)toxicology, pharmacokinetics and pharmaceutics (Figure 1).<\/jats:p>","DOI":"10.1093\/jac\/dkag110","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:47:51Z","timestamp":1774615671000},"source":"Crossref","is-referenced-by-count":3,"title":["A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit"],"prefix":"10.1093","volume":"81","author":[{"given":"Sarah","family":"Hendrickx","sequence":"first","affiliation":[{"name":"Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp , Wilrijk (Antwerp) 2610 ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayhan","family":"Ilbeigi","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp , Wilrijk (Antwerp) 2610 ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli S J","family":"Thor\u00e9","sequence":"additional","affiliation":[{"name":"Department of Wildlife, Fish, and Environmental Studies, Swedish University of Agricultural Sciences , Ume\u00e5 907 36 ,","place":["Sweden"]},{"name":"Laboratory of Adaptive Biodynamics, Research Unit of Environmental and Evolutionary Biology, Institute of Life, Earth, and Environment, University of Namur , Namur 5000 ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G","family":"Bertram","sequence":"additional","affiliation":[{"name":"Department of Wildlife, Fish, and Environmental Studies, Swedish University of Agricultural Sciences , Ume\u00e5 907 36 ,","place":["Sweden"]},{"name":"Department of Zoology, Stockholm University , Stockholm 114 18 ,","place":["Sweden"]},{"name":"School of Biological Sciences, Monash University , Clayton Victoria 3800 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"Calvo-Alvarez","sequence":"additional","affiliation":[{"name":"Department of Pharmacological and Biomolecular Sciences, University of Milan , Milan 20133 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sener","family":"Cintesun","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Genetics, Faculty of Arts & Science, Yildiz Technical University , Istanbul 34349 ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Isabel","family":"Ol\u00edas-Molero","sequence":"additional","affiliation":[{"name":"Department of Animal Health, Complutense University Madrid , Madrid 28040 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Corral","sequence":"additional","affiliation":[{"name":"Department of Animal Health, Complutense University Madrid , Madrid 28040 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mateo-Barrientos","sequence":"additional","affiliation":[{"name":"Department of Microbiology & Parasitology, Faculty of Pharmacy, Complutense University Madrid , Madrid 28040 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Estaquier","sequence":"additional","affiliation":[{"name":"INSERM U1124, Universit\u00e9 Paris Cit\u00e9 , Paris 75006 ,","place":["France"]},{"name":"Centre de Recherche du CHU de Qu\u00e9bec, Universit\u00e9 Laval , Qu\u00e9bec, QC, G1V 4G2 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Pomel","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, CNRS BioCIS , 17 avenue des Sciences, Orsay 91400 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Alunda","sequence":"additional","affiliation":[{"name":"Department of Animal Health, Complutense University Madrid , Madrid 28040 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheraz","family":"Gul","sequence":"additional","affiliation":[{"name":"Fraunhofer Institute for Translational Medicine and Pharmacology ITMP , Discovery Research ScreeningPort, Hamburg 22525 ,","place":["Germany"]},{"name":"Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD , Hamburg 22525 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8583-5282","authenticated-orcid":false,"given":"Katrien","family":"Van Bocxlaer","sequence":"additional","affiliation":[{"name":"Skin Research Centre, Hull York Medical School, University of York , York YO10 5DD ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Fr\u00e9zard","sequence":"additional","affiliation":[{"name":"Department of Physiology and Biophysics, Universidade Federal de Minas Gerais , Belo Horizonte, Minas Gerais 31270-901 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Tavares","sequence":"additional","affiliation":[{"name":"i3S - Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto , Porto 4200-135 ,","place":["Portugal"]},{"name":"IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto , Porto 4200-135 ,","place":["Portugal"]},{"name":"ICBAS - Instituto de Ci\u00eancias Biom\u00e9dicas Abel Salazar, Universidade do Porto , Porto 4200-135 ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anabela","family":"Cordeiro Da Silva","sequence":"additional","affiliation":[{"name":"i3S - Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto , Porto 4200-135 ,","place":["Portugal"]},{"name":"IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto , Porto 4200-135 ,","place":["Portugal"]},{"name":"Departamento de Ci\u00eancias Biol\u00f3gicas, Faculdade de Farm\u00e1cia da Universidade do Porto , Porto 4050-313 ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Paola","family":"Costi","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Modena and Reggio Emilia , Modena 41125 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Maes","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp , Wilrijk (Antwerp) 2610 ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4870-3202","authenticated-orcid":false,"given":"Guy","family":"Caljon","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp , Wilrijk (Antwerp) 2610 ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"2026033103104913700_dkag110-B1","doi-asserted-by":"publisher","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","article-title":"TTD: Therapeutic Target Database describing target druggability information","volume":"52","author":"Zhou","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2026033103104913700_dkag110-B2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd4366","article-title":"Phenotypic screening in cancer drug discovery\u2014past, present and future","volume":"13","author":"Moffat","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"2026033103104913700_dkag110-B3","doi-asserted-by":"publisher","first-page":"100557","DOI":"10.1016\/j.ijpddr.2024.100557","article-title":"A multiplexed high throughput screening assay using flow cytometry identifies glycolytic molecular probes in bloodstream form Trypanosoma brucei","volume":"26","author":"Call","year":"2024","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2026033103104913700_dkag110-B4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","article-title":"Computational approaches streamlining drug discovery","volume":"616","author":"Sadybekov","year":"2023","journal-title":"Nature"},{"key":"2026033103104913700_dkag110-B5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13321-023-00754-4","article-title":"Logd7.4 prediction enhanced by transferring knowledge from chromatographic retention time, microscopic pKa and logP","volume":"15","author":"Wang","year":"2023","journal-title":"J Cheminform"},{"key":"2026033103104913700_dkag110-B6","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank Knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2026033103104913700_dkag110-B7","doi-asserted-by":"publisher","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","article-title":"The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods","volume":"52","author":"Zdrazil","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2026033103104913700_dkag110-B8","doi-asserted-by":"publisher","first-page":"9220","DOI":"10.1021\/jm500734a","article-title":"Importance of purity evaluation and the potential of quantitative 1H NMR as a purity assay","volume":"57","author":"Pauli","year":"2014","journal-title":"J Med Chem"},{"key":"2026033103104913700_dkag110-B9","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1039\/D1QI01379C","article-title":"Elemental analysis: an important purity control but prone to manipulations","volume":"9","author":"Kandioller","year":"2022","journal-title":"Inorg Chem Front"},{"key":"2026033103104913700_dkag110-B10","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J Med Chem"},{"key":"2026033103104913700_dkag110-B11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-642-28175-4_7","volume-title":"Drug Discovery in Africa: Impacts of Genomics, Natural Products, Traditional Medicines, Insights into Medicinal Chemistry, and Technology Platforms in Pursuit of New Drugs","author":"Masimirembwa","year":"2012"},{"key":"2026033103104913700_dkag110-B12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12989-020-00344-4","article-title":"Adverse outcome pathways as a tool for the design of testing strategies to support the safety assessment of emerging advanced materials at the nanoscale","volume":"17","author":"Halappanavar","year":"2020","journal-title":"Part Fibre Toxicol"},{"key":"2026033103104913700_dkag110-B13","doi-asserted-by":"publisher","first-page":"21579","DOI":"10.1038\/s41598-024-70321-w","article-title":"Author Correction: AI is a viable alternative to high throughput screening: a 318-target study","volume":"14","author":"Atomwise AIMS Program","year":"2024","journal-title":"Sci Rep"},{"key":"2026033103104913700_dkag110-B14","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.drudis.2021.11.023","article-title":"Enhancing preclinical drug discovery with artificial intelligence","volume":"27","author":"Vijayan","year":"2022","journal-title":"Drug Discov Today"},{"key":"2026033103104913700_dkag110-B15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/9781394167258.ch2","volume-title":"Drug Design Using Machine Learning","author":"Balatti","year":"2022"},{"key":"2026033103104913700_dkag110-B16","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/978-1-0716-0294-2_47","article-title":"In vitro growth inhibition assays of Leishmania spp","volume":"2116","author":"Hendrickx","year":"2020","journal-title":"Methods Mol Biol"},{"key":"2026033103104913700_dkag110-B17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1021\/acsinfecdis.4c00472","article-title":"Discovery and development of an advanced lead for the treatment of African trypanosomiasis","volume":"11","author":"Ilbeigi","year":"2025","journal-title":"ACS Infect Dis"},{"key":"2026033103104913700_dkag110-B18","doi-asserted-by":"publisher","first-page":"e1461","DOI":"10.1371\/journal.pntd.0001461","article-title":"Genetic engineering of Trypanosoma (Dutonella) vivax and in vitro differentiation under axenic conditions","volume":"5","author":"D'Archivio","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"2026033103104913700_dkag110-B19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/0014-4894(70)90120-7","article-title":"Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose","volume":"28","author":"Lanham","year":"1970","journal-title":"Exp Parasitol"},{"key":"2026033103104913700_dkag110-B20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1196\/annals.1307.020","article-title":"Use of the miniature anion exchange centrifugation technique to isolate Trypanosoma evansi from goats","volume":"1026","author":"Gutierrez","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"2026033103104913700_dkag110-B21","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1590\/S0102-311X1999000400002","article-title":"The evolution of pathogenic trypanosomes","volume":"15","author":"Stevens","year":"1999","journal-title":"Cad Saude Publica"},{"key":"2026033103104913700_dkag110-B22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijpddr.2022.05.001","article-title":"Nucleoside analogues for the treatment of animal trypanosomiasis","volume":"19","author":"Mabille","year":"2022","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2026033103104913700_dkag110-B23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/jac\/dkp500","article-title":"In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent","volume":"65","author":"Seifert","year":"2010","journal-title":"JAntimicrobChemother"},{"key":"2026033103104913700_dkag110-B24","doi-asserted-by":"publisher","first-page":"e0007885","DOI":"10.1371\/journal.pntd.0007885","article-title":"In-depth comparison of cell-based methodological approaches to determine drug susceptibility of visceral Leishmania isolates","volume":"13","author":"Hendrickx","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"2026033103104913700_dkag110-B25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/tropicalmed4020082","article-title":"Drug discovery for Chagas disease: impact of different host cell lines on assay performance and hit compound selection","volume":"4","author":"Franco","year":"2019","journal-title":"Trop Med Infect Dis"},{"key":"2026033103104913700_dkag110-B26","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.3389\/fimmu.2018.01569","article-title":"Trypanosoma cruzi infection induces cellular stress response and senescence-like phenotype in murine fibroblasts","volume":"9","author":"Guimar\u00e3es-Pinto","year":"2018","journal-title":"Front Immunol"},{"key":"2026033103104913700_dkag110-B27","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/microorganisms9020406","article-title":"Identification of Trypanosoma cruzi growth inhibitors with activity in vivo within a collection of licensed drugs","volume":"9","author":"Martinez-Peinado","year":"2021","journal-title":"Microorganisms"},{"key":"2026033103104913700_dkag110-B28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ijpddr.2015.10.001","article-title":"Development and application of a sensitive, phenotypic, high-throughput image-based assay to identify compound activity against Trypanosoma cruzi amastigotes","volume":"5","author":"Sykes","year":"2015","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2026033103104913700_dkag110-B29","doi-asserted-by":"publisher","first-page":"e02156-18","DOI":"10.1128\/AAC.02156-18","article-title":"Imidazole derivatives as promising agents for the treatment of Chagas disease","volume":"63","author":"de Ara\u00fajo","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033103104913700_dkag110-B30","doi-asserted-by":"publisher","first-page":"116256","DOI":"10.1016\/j.ejmech.2024.116256","article-title":"Hit-to-lead optimization of 2-aminoquinazolines as anti-microbial agents against Leishmania donovani","volume":"269","author":"Das","year":"2024","journal-title":"Eur J Med Chem"},{"key":"2026033103104913700_dkag110-B31","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1093\/jac\/dkab226","article-title":"An adamantamine derivative as a drug candidate for the treatment of visceral leishmaniasis","volume":"76","author":"Pomel","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2026033103104913700_dkag110-B32","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1007\/s00436-018-6059-4","article-title":"Impact of primary mouse macrophage cell types on Leishmania infection and in vitro drug susceptibility","volume":"117","author":"Van den Kerkhof","year":"2018","journal-title":"Parasitol Res"},{"key":"2026033103104913700_dkag110-B33","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3390\/microorganisms10061243","article-title":"Leishmania infantum infection of primary human myeloid cells","volume":"10","author":"Picard","year":"2022","journal-title":"Microorganisms"},{"key":"2026033103104913700_dkag110-B34","doi-asserted-by":"publisher","first-page":"18989","DOI":"10.1038\/s41598-019-55474-3","article-title":"Murine infection with bioluminescent Leishmania infantum axenic amastigotes applied to drug discovery","volume":"9","author":"Mendes Costa","year":"2019","journal-title":"Sci Rep"},{"key":"2026033103104913700_dkag110-B35","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.1128\/AAC.00866-09","article-title":"In vitro sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity for macrophage host cells","volume":"53","author":"da Luz","year":"2009","journal-title":"AntimicrobAgents Chemother"},{"key":"2026033103104913700_dkag110-B36","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1128\/AAC.00548-09","article-title":"In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences","volume":"53","author":"Vermeersch","year":"2009","journal-title":"AntimicrobAgents Chemother"},{"key":"2026033103104913700_dkag110-B37","doi-asserted-by":"publisher","first-page":"108144","DOI":"10.1016\/j.isci.2023.108144","article-title":"Deciphering the mechanism of action of VP343, an antileishmanial drug candidate, in Leishmania infantum","volume":"26","author":"Obeid","year":"2023","journal-title":"iScience"},{"key":"2026033103104913700_dkag110-B38","doi-asserted-by":"publisher","first-page":"103036","DOI":"10.1016\/j.media.2023.103036","article-title":"FiCRoN, a deep learning-based algorithm for the automatic determination of intracellular parasite burden from fluorescence microscopy images","volume":"91","author":"Juez-Castillo","year":"2024","journal-title":"Med Image Anal"},{"key":"2026033103104913700_dkag110-B39","doi-asserted-by":"publisher","first-page":"e0201747","DOI":"10.1371\/journal.pone.0201747","article-title":"Development of an automated image analysis protocol for quantification of intracellular forms of Leishmania spp","volume":"13","author":"Gomes-Alves","year":"2018","journal-title":"PLoS ONE"},{"key":"2026033103104913700_dkag110-B40","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/978-1-4939-9210-2_14","article-title":"In vitro infections of macrophage-like cell lines with Leishmania infantum for drug screening","volume":"1971","author":"Santar\u00e9m","year":"2019","journal-title":"Methods Mol Biol"},{"key":"2026033103104913700_dkag110-B41","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1007\/s00436-018-6084-3","article-title":"Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi","volume":"117","author":"Fonseca-Berzal","year":"2018","journal-title":"Parasitol Res"},{"key":"2026033103104913700_dkag110-B42","doi-asserted-by":"publisher","first-page":"e0258292","DOI":"10.1371\/journal.pone.0258292","article-title":"Drug repurposing for Chagas disease: in vitro assessment of nimesulide against Trypanosoma cruzi and insights on its mechanisms of action","volume":"16","author":"Trindade","year":"2021","journal-title":"PLoS ONE"},{"key":"2026033103104913700_dkag110-B43","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/femsre\/fuw018","article-title":"Alice in microbes\u2019 land: adaptations and counter-adaptations of vector-borne parasitic protozoa and their hosts","volume":"40","author":"Caljon","year":"2016","journal-title":"FEMS Microbiol Rev"},{"key":"2026033103104913700_dkag110-B44","doi-asserted-by":"publisher","first-page":"e0009602","DOI":"10.1371\/journal.pntd.0009602","article-title":"Rate-of-Kill (RoK) assays to triage large compound sets for Chagas disease drug discovery: application to GSK Chagas Box","volume":"15","author":"Cantizani","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"2026033103104913700_dkag110-B45","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1128\/AAC.00398-13","article-title":"Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis","volume":"57","author":"Wenzler","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033103104913700_dkag110-B46","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1093\/jac\/dkv417","article-title":"Pentacyclic nitrofurans that rapidly kill nifurtimox-resistant trypanosomes","volume":"71","author":"Bruhn","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2026033103104913700_dkag110-B47","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/jac\/dkw409","article-title":"In vitro \u2018time-to-kill\u2019 assay to assess the cidal activity dynamics of current reference drugs against Leishmania donovani and Leishmania infantum","volume":"72","author":"Maes","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2026033103104913700_dkag110-B48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijpddr.2018.01.006","article-title":"In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series","volume":"8","author":"Van den Kerkhof","year":"2018","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2026033103104913700_dkag110-B49","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3390\/ani13101650","article-title":"Leishmania animal models used in drug discovery: a systematic review","volume":"13","author":"van der Ende","year":"2023","journal-title":"Animals"},{"key":"2026033103104913700_dkag110-B50","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"key":"2026033103104913700_dkag110-B51","doi-asserted-by":"publisher","first-page":"1051647","DOI":"10.3389\/fimmu.2022.1051647","article-title":"Tipping the balance between erythroid cell differentiation and induction of anemia in response to the inflammatory pathology associated with chronic trypanosome infections","volume":"13","author":"Nguyen","year":"2022","journal-title":"Front Immunol"},{"key":"2026033103104913700_dkag110-B52","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.pt.2008.05.010","article-title":"Contributions of experimental mouse models to the understanding of African trypanosomiasis","volume":"24","author":"Antoine-Moussiaux","year":"2008","journal-title":"Trends Parasitol"},{"key":"2026033103104913700_dkag110-B53","doi-asserted-by":"publisher","first-page":"e0218441","DOI":"10.1371\/journal.pone.0218441","article-title":"Route of inoculation influences Trypanosoma congolense and Trypanosoma brucei brucei virulence in Swiss white mice","volume":"14","author":"Ndungu","year":"2019","journal-title":"PLoS ONE"},{"key":"2026033103104913700_dkag110-B54","doi-asserted-by":"publisher","first-page":"5564","DOI":"10.1038\/s41467-019-13522-6","article-title":"Combining tubercidin and cordycepin scaffolds results in highly active candidates to treat late-stage sleeping sickness","volume":"10","author":"Hulpia","year":"2019","journal-title":"Nat Commun"},{"key":"2026033103104913700_dkag110-B55","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1017\/S0031182000000822","article-title":"In vitro cloning of animal-infective bloodstream forms of Trypanosoma brucei","volume":"80","author":"Hirumi","year":"1980","journal-title":"Parasitology"},{"key":"2026033103104913700_dkag110-B56","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00436-012-3183-4","article-title":"Antiprotozoal activity of ferroquine","volume":"112","author":"Pomel","year":"2013","journal-title":"Parasitol Res"},{"key":"2026033103104913700_dkag110-B57","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1128\/AAC.02490-15","article-title":"Activity of bisnaphthalimidopropyl derivatives against Trypanosoma brucei","volume":"60","author":"Graca","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033103104913700_dkag110-B58","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0166-6851(97)00160-6","article-title":"Cell density triggers slender to stumpy differentiation of Trypanosoma brucei bloodstream forms in culture","volume":"90","author":"Reuner","year":"1997","journal-title":"Mol Biochem Parasitol"},{"key":"2026033103104913700_dkag110-B59","doi-asserted-by":"publisher","first-page":"e2571","DOI":"10.1371\/journal.pntd.0002571","article-title":"Highly sensitive in vivo imaging of Trypanosoma brucei expressing \u201cred-shifted\u201d luciferase","volume":"7","author":"McLatchie","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"2026033103104913700_dkag110-B60","doi-asserted-by":"publisher","first-page":"e1151","DOI":"10.1371\/journal.pntd.0001151","article-title":"SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis","volume":"5","author":"Jacobs","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"2026033103104913700_dkag110-B61","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jmoldx.2014.02.006","article-title":"Diagnosis of trypanosomatid infections: targeting the spliced leader RNA","volume":"16","author":"Gonz\u00e1lez-Andrade","year":"2014","journal-title":"J Mol Diagn"},{"key":"2026033103104913700_dkag110-B62","doi-asserted-by":"publisher","first-page":"348","DOI":"10.4269\/ajtmh.1993.48.348","article-title":"Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human Chagasic cardiomyopathy","volume":"48","author":"Jones","year":"1993","journal-title":"Am J Trop Med Hyg"},{"key":"2026033103104913700_dkag110-B63","doi-asserted-by":"publisher","first-page":"e12783","DOI":"10.1111\/tid.12783","article-title":"An autopsy-based study of Trypanosoma cruzi persistence in organs of chronic chagasic patients and its relevance for transplantation","volume":"19","author":"Benvenuti","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"2026033103104913700_dkag110-B64","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.micinf.2011.06.002","article-title":"Evidence for Trypanosoma cruzi in adipose tissue in human chronic Chagas disease","volume":"13","author":"Ferreira","year":"2011","journal-title":"Microbes Infect"},{"key":"2026033103104913700_dkag110-B65","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1080\/17460441.2020.1806233","article-title":"Animal models of Chagas disease and their translational value to drug development","volume":"15","author":"Chatelain","year":"2020","journal-title":"Expert Opin Drug Discov"},{"key":"2026033103104913700_dkag110-B66","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/jac\/dkaa030","article-title":"Assessing the effectiveness of AS-48 in experimental mice models of Chagas\u2019 disease","volume":"75","author":"Mart\u00edn-Escolano","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2026033103104913700_dkag110-B67","doi-asserted-by":"publisher","first-page":"e02098-16","DOI":"10.1128\/AAC.02098-16","article-title":"Antitrypanosomal activity of sterol 14\u03b1-demethylase (CYP51) inhibitors VNI and VFV in the Swiss mouse models of Chagas disease induced by the Trypanosoma cruzi Y strain","volume":"61","author":"Guedes-da-Silva","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033103104913700_dkag110-B68","doi-asserted-by":"publisher","first-page":"e240057","DOI":"10.1590\/0074-02760240057","article-title":"Drug screening and development cascade for Chagas disease: an update of in vitro and in vivo experimental models","volume":"119","author":"Soeiro","year":"2024","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2026033103104913700_dkag110-B69","doi-asserted-by":"publisher","first-page":"e2977","DOI":"10.1371\/journal.pntd.0002977","article-title":"Synergy testing of FDA-approved drugs identifies potent drug combinations against Trypanosoma cruzi","volume":"8","author":"Planer","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2026033103104913700_dkag110-B70","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/j.1462-5822.2012.01764.x","article-title":"Mechanisms of Trypanosoma cruzi persistence in Chagas disease","volume":"14","author":"Nagajyothi","year":"2012","journal-title":"Cell Microbiol"},{"key":"2026033103104913700_dkag110-B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/RRTM.S415273","article-title":"State-of-the-art in the drug discovery pathway for Chagas disease: a framework for drug development and target validation","volume":"14","author":"Gabald\u00f3n-Figueira","year":"2023","journal-title":"Res Rep Trop Med"},{"key":"2026033103104913700_dkag110-B72","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1021\/acsinfecdis.0c00061","article-title":"C57BL\/6 \u03b1-1,3-galactosyltransferase knockout mouse as an animal model for experimental Chagas disease","volume":"6","author":"Ayala","year":"2020","journal-title":"ACS Infect Dis"},{"key":"2026033103104913700_dkag110-B73","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1046\/j.1365-3156.2001.00754.x","article-title":"Monitoring drug resistance in leishmaniasis","volume":"6","author":"Croft","year":"2001","journal-title":"TropMedIntHealth"},{"key":"2026033103104913700_dkag110-B74","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"ClinMicrobiolRev"},{"key":"2026033103104913700_dkag110-B75","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1017\/S0031182016002031","article-title":"Evaluating drug resistance in visceral leishmaniasis: the challenges","volume":"145","author":"Hendrickx","year":"2018","journal-title":"Parasitology"},{"key":"2026033103104913700_dkag110-B76","doi-asserted-by":"publisher","first-page":"Unit 19.2","DOI":"10.1002\/0471142735.im1902s28","article-title":"Animal models for the analysis of immune responses to leishmaniasis","volume":"Chapter 19","author":"Sacks","year":"2001","journal-title":"Curr Protoc Immunol"},{"key":"2026033103104913700_dkag110-B77","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.parint.2016.03.008","article-title":"An experimental challenge model of visceral leishmaniasis by Leishmania donovani promastigotes in mice","volume":"65","author":"Katakura","year":"2016","journal-title":"Parasitol Int"},{"key":"2026033103104913700_dkag110-B78","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.3390\/microorganisms9122500","article-title":"Antileishmanial drug discovery and development: time to reset the model?","volume":"9","author":"Ol\u00edas-Molero","year":"2021","journal-title":"Microorganisms"},{"key":"2026033103104913700_dkag110-B79","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/B978-012775390-4\/50232-3","volume-title":"Handbook of Animal Models of Infection","author":"Yardley","year":"1999"},{"key":"2026033103104913700_dkag110-B80","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fcimb.2019.00030","article-title":"Understanding resistance vs. susceptibility in visceral leishmaniasis using mouse models of Leishmania infantum infection","volume":"9","author":"P\u00e9rez-Cabezas","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"2026033103104913700_dkag110-B81","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13071-016-1412-x","article-title":"Regulation of immunity during visceral Leishmania infection","volume":"9","author":"Rodrigues","year":"2016","journal-title":"Parasit Vectors"},{"key":"2026033103104913700_dkag110-B82","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.3389\/fimmu.2018.02958","article-title":"CD4(+) T cells Alter the stromal microenvironment and repress medullary erythropoiesis in murine visceral leishmaniasis","volume":"9","author":"Preham","year":"2018","journal-title":"Front Immunol"},{"key":"2026033103104913700_dkag110-B83","doi-asserted-by":"publisher","first-page":"e0163604","DOI":"10.1371\/journal.pone.0163604","article-title":"CD4+ recent thymic emigrants are recruited into granulomas during Leishmania donovani infection but have limited capacity for cytokine production","volume":"11","author":"Moore","year":"2016","journal-title":"PLoS ONE"},{"key":"2026033103104913700_dkag110-B84","doi-asserted-by":"publisher","first-page":"e0005924","DOI":"10.1371\/journal.pntd.0005924","article-title":"New insights into experimental visceral leishmaniasis: real-time in vivo imaging of Leishmania donovani virulence","volume":"11","author":"Melo","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2026033103104913700_dkag110-B85","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1128\/iai.58.12.3893-3898.1990","article-title":"Defect in the tissue cellular immune response: experimental visceral leishmaniasis in euthymic C57BL\/6 ep\/ep mice","volume":"58","author":"Squires","year":"1990","journal-title":"Infect Immun"},{"key":"2026033103104913700_dkag110-B86","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13071-016-1413-9","article-title":"Study of Leishmania pathogenesis in mice: experimental considerations","volume":"9","author":"Loeuillet","year":"2016","journal-title":"Parasit Vectors"},{"key":"2026033103104913700_dkag110-B87","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.pt.2004.08.009","article-title":"Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis","volume":"20","author":"Engwerda","year":"2004","journal-title":"Trends Parasitol"},{"key":"2026033103104913700_dkag110-B88","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cyto.2018.07.001","article-title":"The impact of IL-10 dynamic modulation on host immune response against visceral leishmaniasis","volume":"112","author":"Mesquita","year":"2018","journal-title":"Cytokine"},{"key":"2026033103104913700_dkag110-B89","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/jac\/dky450","article-title":"Miltefosine enhances the fitness of a non-virulent drug-resistant Leishmania infantum strain","volume":"74","author":"Eberhardt","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2026033103104913700_dkag110-B90","doi-asserted-by":"publisher","first-page":"e0007133","DOI":"10.1371\/journal.pntd.0007133","article-title":"A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery","volume":"13","author":"\u00c1lvarez-Velilla","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"2026033103104913700_dkag110-B91","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.4049\/jimmunol.166.3.1912","article-title":"The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response","volume":"166","author":"Melby","year":"2001","journal-title":"JImmunol"},{"key":"2026033103104913700_dkag110-B92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S0036-46652014000100001","article-title":"Animal models for the study of leishmaniasis","volume":"56","author":"Lor\u00eda-Cervera","year":"2014","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"2026033103104913700_dkag110-B93","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.1038\/s41598-020-61662-3","article-title":"Establishment, optimisation and quantitation of a bioluminescent murine infection model of visceral leishmaniasis for systematic vaccine screening","volume":"10","author":"Ong","year":"2020","journal-title":"Sci Rep"},{"key":"2026033103104913700_dkag110-B94","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1080\/21505594.2019.1649587","article-title":"Efficient infection of hamster with Leishmania donovani by retro-orbital inoculation","volume":"10","author":"Jim\u00e9nez-Ant\u00f3n","year":"2019","journal-title":"Virulence"},{"key":"2026033103104913700_dkag110-B95","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jmoldx.2017.12.003","article-title":"Evaluation of a pan-Leishmania spliced-leader RNA detection method in human blood and experimentally infected Syrian golden hamsters","volume":"20","author":"Eberhardt","year":"2018","journal-title":"J Mol Diagn"},{"key":"2026033103104913700_dkag110-B96","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/infdis\/jiae219","article-title":"Spliced-leader RNA as a dynamic marker for monitoring viable Leishmania parasites during and after treatment","volume":"230","author":"Hendrickx","year":"2024","journal-title":"J Infect Dis"},{"key":"2026033103104913700_dkag110-B97","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"2026033103104913700_dkag110-B98","doi-asserted-by":"publisher","first-page":"e2567","DOI":"10.1371\/journal.pntd.0002567","article-title":"Impairment of T cell function in parasitic infections","volume":"8","author":"Rodrigues","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"Pt 2","key":"2026033103104913700_dkag110-B99","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1017\/S0031182000058303","article-title":"Sex differences and cross-immunity in DBA\/2 mice infected with L. mexicana and L. major","volume":"96","author":"Alexander","year":"1988","journal-title":"Parasitology"},{"key":"2026033103104913700_dkag110-B100","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1128\/iai.55.11.2802-2806.1987","article-title":"Metacyclogenesis is a major determinant of Leishmania promastigote virulence and attenuation","volume":"55","author":"da Silva","year":"1987","journal-title":"Infect Immun"},{"key":"2026033103104913700_dkag110-B101","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/expr.2001.4656","article-title":"A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation","volume":"99","author":"Sp\u00e4th","year":"2001","journal-title":"Exp Parasitol"},{"key":"2026033103104913700_dkag110-B102","doi-asserted-by":"publisher","first-page":"564","DOI":"10.4049\/jimmunol.135.1.564","article-title":"Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes","volume":"135","author":"Sacks","year":"1985","journal-title":"J Immunol"},{"key":"2026033103104913700_dkag110-B103","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1128\/IAI.71.5.2674-2683.2003","article-title":"The levels and patterns of cytokines produced by CD4T lymphocytes of BALB\/c mice infected with Leishmania major by inoculation into the ear dermis depend on the infectiousness and size of the inoculum","volume":"71","author":"Lang","year":"2003","journal-title":"Infect Immun"},{"key":"2026033103104913700_dkag110-B104","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s42003-019-0323-8","article-title":"Quantifying Leishmania metacyclic promastigotes from individual sandfly bites reveals the efficiency of vector transmission","volume":"2","author":"Giraud","year":"2019","journal-title":"Commun Biol"},{"key":"2026033103104913700_dkag110-B105","doi-asserted-by":"publisher","first-page":"10125","DOI":"10.1073\/pnas.0802331105","article-title":"Quantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies","volume":"105","author":"Kimblin","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026033103104913700_dkag110-B106","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijpddr.2019.02.002","article-title":"Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis","volume":"11","author":"Van Bocxlaer","year":"2019","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2026033103104913700_dkag110-B107","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ijpddr.2019.06.003","article-title":"Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis","volume":"11","author":"Caridha","year":"2019","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2026033103104913700_dkag110-B108","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1126\/science.1636090","article-title":"Establishment of stable, cell-mediated immunity that makes \u201csusceptible\u201d mice resistant to Leishmania major","volume":"257","author":"Bretscher","year":"1992","journal-title":"Science"},{"key":"2026033103104913700_dkag110-B109","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1462-5822.2004.00468.x","article-title":"Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice","volume":"7","author":"Lang","year":"2005","journal-title":"Cell Microbiol"},{"key":"2026033103104913700_dkag110-B110","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/1521-4141(200003)30:3&lt;840::AID-IMMU840&gt;3.0.CO;2-L","article-title":"Site of antigen delivery can influence T cell priming: pulmonary environment promotes preferential Th2-type differentiation","volume":"30","author":"Constant","year":"2000","journal-title":"Eur J Immunol"},{"key":"2026033103104913700_dkag110-B111","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/cmi.12297","article-title":"Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection","volume":"16","author":"Lewis","year":"2014","journal-title":"Cell Microbiol"},{"key":"2026033103104913700_dkag110-B112","doi-asserted-by":"publisher","first-page":"e1005744","DOI":"10.1371\/journal.ppat.1005744","article-title":"The dermis as a delivery site of Trypanosoma brucei for tsetse flies","volume":"12","author":"Caljon","year":"2016","journal-title":"PLoS Pathog"},{"key":"2026033103104913700_dkag110-B113","doi-asserted-by":"publisher","first-page":"e17716","DOI":"10.7554\/eLife.17716","article-title":"The skin is a significant but overlooked anatomical reservoir for vector-borne African trypanosomes","volume":"5","author":"Capewell","year":"2016","journal-title":"eLife"},{"key":"2026033103104913700_dkag110-B114","doi-asserted-by":"publisher","first-page":"109741","DOI":"10.1016\/j.celrep.2021.109741","article-title":"Organotypic endothelial adhesion molecules are key for Trypanosoma brucei tropism and virulence","volume":"36","author":"De Niz","year":"2021","journal-title":"Cell Rep"},{"key":"2026033103104913700_dkag110-B115","doi-asserted-by":"publisher","first-page":"7083","DOI":"10.1038\/s41467-022-34757-w","article-title":"Impact of pulmonary African trypanosomes on the immunology and function of the lung","volume":"13","author":"Mabille","year":"2022","journal-title":"Nat Commun"},{"key":"2026033103104913700_dkag110-B116","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/1087057114552623","article-title":"A new experimental model for assessing drug efficacy against Trypanosoma cruzi infection based on highly sensitive in vivo imaging","volume":"20","author":"Lewis","year":"2015","journal-title":"J Biomol Screen"},{"key":"2026033103104913700_dkag110-B117","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.ijpara.2008.04.002","article-title":"Bioluminescent imaging of Trypanosoma cruzi infection","volume":"38","author":"Hyland","year":"2008","journal-title":"Int J Parasitol"},{"key":"2026033103104913700_dkag110-B118","doi-asserted-by":"publisher","first-page":"e1298","DOI":"10.1371\/journal.pntd.0001298","article-title":"Activity in vivo of anti-Trypanosoma cruzi compounds selected from a high throughput screening","volume":"5","author":"Andriani","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"2026033103104913700_dkag110-B119","doi-asserted-by":"publisher","first-page":"e740","DOI":"10.1371\/journal.pntd.0000740","article-title":"In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds","volume":"4","author":"Canavaci","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"2026033103104913700_dkag110-B120","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1128\/AAC.00520-15","article-title":"Limited ability of posaconazole to cure both acute and chronic Trypanosoma cruzi infections revealed by highly sensitive in vivo imaging","volume":"59","author":"Francisco","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033103104913700_dkag110-B121","doi-asserted-by":"publisher","first-page":"eadg8105","DOI":"10.1126\/scitranslmed.adg8105","article-title":"Short-course combination treatment for experimental chronic Chagas disease","volume":"15","author":"Gonz\u00e1lez","year":"2023","journal-title":"Sci Transl Med"},{"key":"2026033103104913700_dkag110-B122","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1021\/acsinfecdis.0c00864","article-title":"Bioluminescent imaging identifies thymus, as overlooked colonized organ, in a chronic model of Leishmania donovani mouse visceral leishmaniasis","volume":"7","author":"Dom\u00ednguez-Asenjo","year":"2021","journal-title":"ACS Infect Dis"},{"key":"2026033103104913700_dkag110-B123","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.parint.2016.10.020","article-title":"Imaging visceral leishmaniasis in real time with golden hamster model: monitoring the parasite burden and hamster transcripts to further characterize the immunological responses of the host","volume":"66","author":"Rouault","year":"2017","journal-title":"Parasitol Int"},{"key":"2026033103104913700_dkag110-B124","doi-asserted-by":"publisher","first-page":"16074","DOI":"10.3390\/ijms232416074","article-title":"Comparison of bioluminescent substrates in natural infection models of neglected parasitic diseases","volume":"23","author":"Hendrickx","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026033103104913700_dkag110-B125","doi-asserted-by":"publisher","first-page":"e02048-16","DOI":"10.1128\/AAC.02048-16","article-title":"Use of optical imaging technology in the validation of a new, rapid, cost-effective drug screen as part of a tiered in vivo screening paradigm for development of drugs to treat cutaneous leishmaniasis","volume":"61","author":"Caridha","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033103104913700_dkag110-B126","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s42003-022-03591-7","article-title":"Long-term hematopoietic stem cells as a parasite niche during treatment failure in visceral leishmaniasis","volume":"5","author":"Dirkx","year":"2022","journal-title":"Commun Biol"},{"key":"2026033103104913700_dkag110-B127","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.pt.2024.07.013","article-title":"The immunomicrotope of Leishmania control and persistence","volume":"40","author":"Bogdan","year":"2024","journal-title":"Trends Parasitol"},{"key":"2026033103104913700_dkag110-B128","doi-asserted-by":"publisher","first-page":"e1012181","DOI":"10.1371\/journal.ppat.1012181","article-title":"Long-term hematopoietic stem cells trigger quiescence in Leishmania parasites","volume":"20","author":"Dirkx","year":"2024","journal-title":"PLoS Pathog"},{"key":"2026033103104913700_dkag110-B129","doi-asserted-by":"publisher","first-page":"106612","DOI":"10.1016\/j.ijantimicag.2022.106612","article-title":"Models for cytotoxicity screening of antileishmanial drugs: what has been done so far?","volume":"60","author":"Brioschi","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"2026033103104913700_dkag110-B130","first-page":"407","volume-title":"Public Health and Toxicology Issues in Drug Research","author":"Rajpoot","year":"2024"},{"key":"2026033103104913700_dkag110-B131","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.4049\/jimmunol.1900590","article-title":"Antileishmanial drugs modulate IL-12 expression and inflammasome activation in primary human cells","volume":"204","author":"Andre","year":"2020","journal-title":"J Immunol"},{"key":"2026033103104913700_dkag110-B132","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jep.2006.04.003","article-title":"Anti-infective potential of natural products: how to develop a stronger in vitro \u2018proof-of-concept\u2019","volume":"106","author":"Cos","year":"2006","journal-title":"JEthnopharmacol"},{"key":"2026033103104913700_dkag110-B133","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1002\/cpph.43","article-title":"The Irwin test and functional observational battery (FOB) for assessing the effects of compounds on behavior, physiology, and safety pharmacology in rodents","volume":"83","author":"Mathiasen","year":"2018","journal-title":"Curr Protoc Pharmacol"},{"key":"2026033103104913700_dkag110-B134","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.3390\/pharmaceutics15112523","article-title":"Caco-2 cell line standardization with pharmaceutical requirements and in vitro model suitability for permeability assays","volume":"15","author":"Kus","year":"2023","journal-title":"Pharmaceutics"},{"key":"2026033103104913700_dkag110-B135","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00418-015-1351-1","article-title":"Transepithelial electrical resistance (TEER): a functional parameter to monitor the quality of oviduct epithelial cells cultured on filter supports","volume":"144","author":"Chen","year":"2015","journal-title":"Histochem Cell Biol"},{"key":"2026033103104913700_dkag110-B136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003088-198409010-00001","article-title":"First-pass elimination. Basic concepts and clinical consequences","volume":"9","author":"Pond","year":"1984","journal-title":"Clin Pharmacokinet"},{"key":"2026033103104913700_dkag110-B137","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3109\/01480549709003891","article-title":"First-pass effect: significance of the intestine for absorption and metabolism","volume":"20","author":"Doherty","year":"1997","journal-title":"Drug Chem Toxicol"},{"key":"2026033103104913700_dkag110-B138","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12859-021-04209-1","article-title":"SMILE: systems metabolomics using interpretable learning and evolution","volume":"22","author":"Sha","year":"2021","journal-title":"BMC Bioinform"},{"key":"2026033103104913700_dkag110-B139","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.drudis.2007.10.014","article-title":"Snapshot PK: a rapid rodent in vivo preclinical screening approach","volume":"13","author":"Liu","year":"2008","journal-title":"Drug Discov Today"},{"key":"2026033103104913700_dkag110-B140","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/0976-500X.72350","article-title":"Blood sample collection in small laboratory animals","volume":"1","author":"Parasuraman","year":"2010","journal-title":"J Pharmacol Pharmacother"},{"key":"2026033103104913700_dkag110-B141","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.drudis.2012.09.004","article-title":"A modern in vivo pharmacokinetic paradigm: combining snapshot, rapid and full PK approaches to optimize and expedite early drug discovery","volume":"18","author":"Li","year":"2013","journal-title":"Drug Discov Today"},{"key":"2026033103104913700_dkag110-B142","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/1091581815622442","article-title":"Tolerable levels of nonclinical vehicles and formulations used in studies by multiple routes in multiple species with notes on methods to improve utility","volume":"35","author":"Gad","year":"2016","journal-title":"Int J Toxicol"},{"key":"2026033103104913700_dkag110-B143","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nm1395","article-title":"Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor","volume":"12","author":"Baral","year":"2006","journal-title":"Nat Med"},{"key":"2026033103104913700_dkag110-B144","doi-asserted-by":"publisher","first-page":"e2384","DOI":"10.1371\/journal.pntd.0002384","article-title":"In vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasis","volume":"7","author":"Myburgh","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"2026033103104913700_dkag110-B145","doi-asserted-by":"publisher","first-page":"43088","DOI":"10.1021\/acsomega.3c06508","article-title":"In vitro and in vivo trypanocidal efficacy of nitrofuryl- and nitrothienylazines","volume":"8","author":"Janse van Rensburg","year":"2023","journal-title":"ACS Omega"},{"key":"2026033103104913700_dkag110-B146","doi-asserted-by":"publisher","first-page":"e02356-16","DOI":"10.1128\/AAC.02356-16","article-title":"In vitro, ex vivo, and in vivo activities of diamidines against Trypanosoma congolense and Trypanosoma vivax","volume":"61","author":"Gillingwater","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033103104913700_dkag110-B147","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1128\/AAC.00422-09","article-title":"In vivo investigations of selected diamidine compounds against Trypanosoma evansi using a mouse model","volume":"53","author":"Gillingwater","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033103104913700_dkag110-B148","doi-asserted-by":"publisher","first-page":"852091","DOI":"10.3389\/fimmu.2022.852091","article-title":"Low dose gamma irradiation of Trypanosoma evansi parasites identifies molecular changes that occur to repair radiation damage and gene transcripts that may be involved in establishing disease in mice post-irradiation","volume":"13","author":"Kangethe","year":"2022","journal-title":"Front Immunol"},{"key":"2026033103104913700_dkag110-B149","doi-asserted-by":"publisher","first-page":"e0006790","DOI":"10.1371\/journal.pntd.0006790","article-title":"Isometamidium chloride and homidium chloride fail to cure mice infected with Ethiopian Trypanosoma evansi type A and B","volume":"12","author":"Mekonnen","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2026033103104913700_dkag110-B150","doi-asserted-by":"publisher","first-page":"e0004556","DOI":"10.1371\/journal.pntd.0004556","article-title":"New Trypanosoma evansi type B isolates from Ethiopian dromedary camels","volume":"10","author":"Birhanu","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"2026033103104913700_dkag110-B151","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1017\/S0031182017002098","article-title":"In vitro and in vivo efficacy of diamidines against Trypanosoma equiperdum strains","volume":"145","author":"Gillingwater","year":"2018","journal-title":"Parasitology"},{"key":"2026033103104913700_dkag110-B152","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1093\/gbe\/evx102","article-title":"Genome-wide SNP analysis reveals distinct origins of Trypanosoma evansi and Trypanosoma equiperdum","volume":"9","author":"Cuypers","year":"2017","journal-title":"Genome Biol Evol"},{"key":"2026033103104913700_dkag110-B153","doi-asserted-by":"publisher","first-page":"e0006180","DOI":"10.1371\/journal.pntd.0006180","article-title":"Inhibitors of Trypanosoma cruzi Sir2 related protein 1 as potential drugs against Chagas disease","volume":"12","author":"Gaspar","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2026033103104913700_dkag110-B154","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1093\/jac\/dks273","article-title":"Efficacy and tolerability of oleylphosphocholine (OlPC) in a laboratory model of visceral leishmaniasis","volume":"67","author":"Fortin","year":"2012","journal-title":"JAntimicrobChemother"},{"key":"2026033103104913700_dkag110-B155","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ejps.2018.06.002","article-title":"Pharmacokinetics and disposition of miltefosine in healthy mice and hamsters experimentally infected with Leishmania infantum","volume":"121","author":"Jimenez-Anton","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"2026033103104913700_dkag110-B156","doi-asserted-by":"publisher","first-page":"9318","DOI":"10.1073\/pnas.1820175116","article-title":"Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition","volume":"116","author":"Wyllie","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026033103104913700_dkag110-B157","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1021\/acsinfecdis.1c00139","article-title":"Ex vivo phenotypic screening of two small repurposing drug collections identifies nifuratel as a potential new treatment against visceral and cutaneous leishmaniasis","volume":"7","author":"Dom\u00ednguez-Asenjo","year":"2021","journal-title":"ACS Infect Dis"},{"key":"2026033103104913700_dkag110-B158","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1128\/AAC.05412-11","article-title":"Identification of new antileishmanial leads from hits obtained by high-throughput screening","volume":"56","author":"Zhu","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2026033103104913700_dkag110-B159","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ijantimicag.2019.07.013","article-title":"Development of a target-free high-throughput screening platform for the discovery of antileishmanial compounds","volume":"54","author":"Corman","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"2026033103104913700_dkag110-B160","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1017\/S0031182024000362","article-title":"N(6)-methyltubercidin gives sterile cure in a cutaneous Leishmania amazonensis mouse model","volume":"151","author":"Present","year":"2024","journal-title":"Parasitology"},{"key":"2026033103104913700_dkag110-B161","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s13071-016-1822-9","article-title":"Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl\/6 mice","volume":"9","author":"Pratti","year":"2016","journal-title":"Parasit Vectors"},{"key":"2026033103104913700_dkag110-B162","doi-asserted-by":"publisher","first-page":"e0004660","DOI":"10.1371\/journal.pntd.0004660","article-title":"A luciferase-expressing Leishmania braziliensis line that leads to sustained skin lesions in BALB\/c mice and allows monitoring of miltefosine treatment outcome","volume":"10","author":"Coelho","year":"2016","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/4\/dkag110\/67680729\/dkag110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/4\/dkag110\/67680729\/dkag110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T07:10:55Z","timestamp":1774941055000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkag110\/8565927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":162,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkag110","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,4]]},"article-number":"dkag110"}}